TrialLeukemia2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.
M Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
91 papers cite itlatest 60 shown
this paperpooled ittrialcites it